Risk of damage and mortality in SLE patients fulfilling the ACR or only the SLICC classification criteria. A 10-year, inception cohort study

被引:7
作者
Ines, L. [1 ,2 ,3 ]
Rodrigues, M. [1 ]
Jesus, D. [1 ]
Fonseca, F. P. [1 ,2 ,3 ]
Silva, J. A. P. [1 ,3 ]
机构
[1] Ctr Hosp Univ Coimbra, Dept Rheumatol, Coimbra, Portugal
[2] Univ Beira Interior, Sch Hlth Sci, Coimbra, Portugal
[3] Univ Coimbra, Fac Med, Coimbra, Portugal
关键词
Systemic lupus erythematosus; classification criteria; damage; mortality; inception cohort; prognosis; SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTERNATIONAL COLLABORATING CLINICS; ANTIPHOSPHOLIPID SYNDROME; DISEASE-ACTIVITY; ORGAN DAMAGE; INDEX; SURVIVAL; HYDROXYCHLOROQUINE; VALIDATION; PREDICTORS;
D O I
10.1177/0961203317731534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To compare damage and mortality, from inception up to 10-year follow-up, between SLE patients meeting at baseline the 1997 ACR criteria or only the 2012 SLICC classification criteria. Methods Patients fulfilling the ACR and/or the SLICC classification criteria for SLE were enrolled at inception and followed-up to 10 years at an academic lupus clinic. Damage was defined as SLICC Damage Index (SDI) score 1. We assessed with multivariate Cox models the damage and mortality outcomes, according to SLE classification status at inception, adjusting for potential baseline confounders. Results We recruited 192 patients (69.8% fulfilling at inception the ACR criteria and 30.2% only the SLICC criteria). During follow-up, 24.0% of patients accrued organ damage and 4.2% died. Patients meeting ACR criteria compared to those with SLICC criteria alone presented during follow-up with more cases of lupus nephritis (35.1% versus 13.8%, p<0.01), but less thrombotic antiphospholipid syndrome (4.5% versus 17.2%, p<0.01). The Cox models showed no significant differences in risk for damage [hazard ratio (HR) (95% CI) 0.991 (0.453-2.167)] or death [hazard ratio (HR) (95% CI) 0.694 (0.107-4.506)] between groups. Conclusion The SLE classification status at inception identified different patterns of clinical phenotype, but did not influence damage accrual or mortality up to 10-year follow-up.
引用
收藏
页码:556 / 563
页数:8
相关论文
共 30 条
[1]   International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies [J].
Agmon-Levin, Nancy ;
Damoiseaux, Jan ;
Kallenberg, Cees ;
Sack, Ulrich ;
Witte, Torsten ;
Herold, Manfred ;
Bossuyt, Xavier ;
Musset, Lucille ;
Cervera, Ricard ;
Plaza-Lopez, Aresio ;
Dias, Carlos ;
Sousa, Maria Jose ;
Radice, Antonella ;
Eriksson, Catharina ;
Hultgren, Olof ;
Viander, Markku ;
Khamashta, Munther ;
Regenass, Stephan ;
Coelho Andrade, Luis Eduardo ;
Wiik, Allan ;
Tincani, Angela ;
Ronnelid, Johan ;
Bloch, Donald B. ;
Fritzler, Marvin J. ;
Chan, Edward K. L. ;
Garcia-De la Torre, I. ;
Konstantinov, Konstantin N. ;
Lahita, Robert ;
Wilson, Merlin ;
Vainio, Olli ;
Fabien, Nicole ;
Sinico, Renato Alberto ;
Meroni, Pierluigi ;
Shoenfeld, Yehuda .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) :17-23
[2]   Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus - the Hopkins Lupus Cohort [J].
Al Sawah, Sarah ;
Zhang, Xiang ;
Zhu, Baojin ;
Magder, Laurence S. ;
Foster, Shonda A. ;
Iikuni, Noriko ;
Petri, Michelle .
LUPUS SCIENCE & MEDICINE, 2015, 2 (01)
[3]   Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus:: Data from LUMINA, a multiethnic US cohort (LUMINA L) [J].
Alarcon, Graciela S. ;
McGwin, Gerald ;
Bertoli, Ana M. ;
Fessler, Barri J. ;
Calvo-Alen, Jaime ;
Bastian, Holly M. ;
Vila, Luis M. ;
Reveille, John D. .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (09) :1168-1172
[4]   Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort [J].
Bruce, Ian N. ;
O'Keeffe, Aidan G. ;
Farewell, Vern ;
Hanly, John G. ;
Manzi, Susan ;
Su, Li ;
Gladman, Dafna D. ;
Bae, Sang-Cheol ;
Sanchez-Guerrero, Jorge ;
Romero-Diaz, Juanita ;
Gordon, Caroline ;
Wallace, Daniel J. ;
Clarke, Ann E. ;
Bernatsky, Sasha ;
Ginzler, Ellen M. ;
Isenberg, David A. ;
Rahman, Anisur ;
Merrill, Joan T. ;
Alarcon, Graciela S. ;
Fessler, Barri J. ;
Fortin, Paul R. ;
Petri, Michelle ;
Steinsson, Kristjan ;
Dooley, Mary Anne ;
Khamashta, Munther A. ;
Ramsey-Goldman, Rosalind ;
Zoma, Asad A. ;
Sturfelt, Gunnar K. ;
Nived, Ola ;
Aranow, Cynthia ;
Mackay, Meggan ;
Ramos-Casals, Manuel ;
van Vollenhoven, Ronald F. ;
Kalunian, Kenneth C. ;
Ruiz-Irastorza, Guillermo ;
Lim, Sam ;
Kamen, Diane L. ;
Peschken, Christine A. ;
Inanc, Murat ;
Urowitz, Murray B. .
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (09) :1706-1713
[5]  
Canhao H, 2011, ACTA REUMATOL PORT, V36, P45
[6]   Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients [J].
Cervera, R ;
Khamashta, MA ;
Font, J ;
Sebastiani, GD ;
Gil, A ;
Lavilla, P ;
Mejía, JC ;
Aydintug, AC ;
Chwalinska-Sadowska, H ;
de Ramón, E ;
Fernández-Nebro, A ;
Galeazzi, M ;
Valen, M ;
Mathieu, A ;
Houssiau, FD ;
Caro, N ;
Alba, P ;
Ramos-Casals, M ;
Ingelmo, M ;
Hughes, GRV .
MEDICINE, 2003, 82 (05) :299-308
[7]  
COHEN A S, 1971, Bulletin on the Rheumatic Diseases, V21, P643
[8]   The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort [J].
Conti, F. ;
Ceccarelli, F. ;
Perricone, C. ;
Leccese, I. ;
Massaro, L. ;
Pacucci, V. A. ;
Truglia, S. ;
Miranda, F. ;
Spinelli, F. R. ;
Alessandri, C. ;
Valesini, G. .
LUPUS, 2016, 25 (07) :719-726
[9]   Long-term prognosis and causes of death in systemic lupus erythematosus [J].
Doria, Andrea ;
Iaccarino, Luca ;
Ghirardello, Anna ;
Zampieri, Sandra ;
Arienti, Silvia ;
Sarzi-Puttini, Piercarlo ;
Atzeni, Fabiola ;
Piccoli, Antonio ;
Todesco, Silvano .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (08) :700-706
[10]  
Duarte C, 2011, SYSTEMIC LUPUS ERYTHEMATOSUS, 5TH EDITION, P673